Financial

Shareholders say “not so fast!” Revive suit against Cardiovascular Systems

Here we go again, shareholders bring lawsuit back to life after recent action… Shareholders revive class-action kickbacks suit against Cardiovascular Systems Shareholders revived a purported class-action kickbacks lawsuit against Cardiovascular Systems (NSDQ:CSII) that was dismissed without prejudice earlier this year, citing in the new complaint a $25 million judgment against the company […]

Philips expands technology leadership in image-guided therapy with acquisition of CardioProlific Inc.

Press Release | June 29, 2017 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial details of the transaction will not be disclosed. […]

Royal Philips Electronics N.V. (PHG) Slams Down $2.16 Billion for Spectranetics (SPNC)

6/28/2017 5:53:44 AM  Philips To Acquire The Spectranetics Corporation To Accelerate Expansion In Image-Guided Therapy Devices To Treat Cardiac And Peripheral Vascular Disease  AMSTERDAM, the Netherlands and COLORADO SPRINGS, Colo., June 28, 2017 (GLOBE NEWSWIRE) — Royal Philips(NYSE:PHG) (AEX:PHIA), a global leader in health technology, and The Spectranetics Corporation (NASDAQ:SPNC), a U.S.-based global […]

United States Recovers $13.4 Million in False Claims Act Case for Medically Unnecessary Cardiac Monitoring Services

NEWS PROVIDED BY Whistleblower Law Collaborative  26 Jun, 2017, 15:37 ET BOSTON, June 26, 2017 /PRNewswire/ — Attorneys Suzanne E. Durrell and Robert M. Thomas, Jr. of the Whistleblower Law Collaborative are pleased to announce that the United States has settled a federal False Claims Act case brought by their whistleblower client, Eben Steele, against Medi-Lynx Cardiac Monitoring, LLC, AMI […]

Acessa Health Inc. Acquires The Acessa System For Treatment Of Symptomatic Uterine Fibroids

AUSTIN, Texas–(BUSINESS WIRE)–Acessa Health Inc. announced today that it has acquired the Acessa® System for the treatment of symptomatic uterine fibroids, following the close of an asset purchase agreement with Halt Medical Inc. Concurrent with the acquisition, Acessa Health completed the first closing of a planned $30 million Series A […]

San Diego’s REVA Medical Completes $34.6 Million Funding Round

SAN DIEGO, June 19, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announces that it has closed the second tranche and, therefore, has completed the financing transaction announced in April 2017 and approved by the Company’s shareholders on June 1, 2017. Completion occurred on June 16, […]